NexgenRx Inc.
NXG.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 199.25% | 102.53% | 443.65% | 4,242.44% | 1,124.09% |
| Total Depreciation and Amortization | 163.07% | 213.06% | 24.16% | 15.21% | 7.61% |
| Total Amortization of Deferred Charges | -62.80% | -78.87% | -9.14% | -9.14% | -9.14% |
| Total Other Non-Cash Items | 0.11% | 0.30% | 1,082.07% | 607.37% | 1,003.52% |
| Change in Net Operating Assets | 212.08% | 208.08% | -11.13% | -504.25% | -542.91% |
| Cash from Operations | 130.76% | 332.69% | 173.11% | 25.09% | 64.42% |
| Capital Expenditure | -163.26% | -241.51% | -362.77% | -179.67% | -9.20% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 44.81% | 44.16% | -48.99% | -144.47% | -96.16% |
| Cash from Investing | 11.73% | 1.46% | -115.40% | -158.60% | -70.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 12.02% | -8.11% | -29.61% | -40.38% | -39.95% |
| Issuance of Common Stock | -- | -- | -100.00% | -66.67% | -66.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -42.92% | -42.49% | -42.36% | -1.98% | 1.87% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -45.89% | -71.23% | -74.70% | -22.96% | -17.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 424.16% | 1,817.77% | 782.45% | -41.98% | 418.23% |